Have you or your loved ones been diagnosed with central nervous system lymphoma?

You may be eligible to participate in a central nervous system lymphoma clinical trial.

Have you or your loved ones been diagnosed with central nervous system lymphoma? You may be eligible to participate in a central nervous system lymphoma clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Lymphoma in Houston TX
NCT02420795 | Phase 1 phase 2 | Interventional

Have you or your loved ones been diagnosed with central nervous system lymphoma?

You may be eligible to participate in a central nervous system lymphoma clinical trial.

Have you or your loved ones been diagnosed with central nervous system lymphoma? You may be eligible to participate in a central nervous system lymphoma clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 60 Participants

This phase I/II trial studies the side effects and the best dose of v-akt murine thymoma viral oncogene homolog (Akt)/mitogen-activated protein kinase 1(ERK) inhibitor ONC201 and to see how well it works in treating patients with non-Hodgkin's lymphoma that has returned after a period of improvement or does not respond to treatment. Akt/ERK inhibitor ONC201 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Where you'll go

Selected location

Available locations
M D Anderson Cancer Center

M D Anderson Cancer Center

Recruiting 1515 Holcombe Boulevard, Houston, TX, USA 77030

Interested in participating?
Selected location

University of Texas MD Anderson Cancer Center

1515 Holcombe Boulevard, Houston, TX, USA 77030

Krystal Merdinger +12159666244
krystal.merdinger@oncoceutics.com


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.